Phoenix Biotech Acquisition Corp. – NASDAQ:PBAXU

Phoenix Biotech Acquisition Corp. stock price today

$6.32
-4.05
-39.05%
Financial Health
0
1
2
3
4
5
6
7
8
9

Phoenix Biotech Acquisition Corp. stock price monthly change

-5.98%
month

Phoenix Biotech Acquisition Corp. stock price quarterly change

-2.81%
quarter

Phoenix Biotech Acquisition Corp. stock price yearly change

+0.48%
year

Phoenix Biotech Acquisition Corp. key metrics

Market Cap
 36.54M
Enterprise value
 185.10T
P/E
 -489686902.27
EV/Sales
 N/A
EV/EBITDA
 -428912470.91
Price/Sales
 N/A
Price/Book
 1085936.39
PEG ratio
 N/A
EPS
 -0.32
Revenue
 N/A
EBITDA
 -5.77M
Income
 -2.40M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Phoenix Biotech Acquisition Corp. stock price history

Phoenix Biotech Acquisition Corp. stock forecast

Phoenix Biotech Acquisition Corp. financial statements

Profit Margin

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU): Profit margin
Dec 2022 254.83K -262.67K -103.08%
Mar 2023 0 -373.15K
Jun 2023 0 -1.43M
Sep 2023 0 -334.02K
PBAXU income statement history

Debt to Assets

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU): Debt to assets
Dec 2022 42367032 39.89M 94.17%
Mar 2023 14430169 12.44M 86.23%
Jun 2023 14110263 13.56M 96.11%
Sep 2023 8470621 13.95M 164.69%
PBAXU balance sheet history

Cash Flow

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU): Cash Flow
Dec 2022 -373.1K 180.71M -138
Mar 2023 -197.77K -100K 0
Jun 2023 -883.09K 285.23K 525K
Sep 2023 -256.12K 5.68M -5.41M
PBAXU cash flow history

Phoenix Biotech Acquisition Corp. other data

Frequently Asked Questions (FAQ)

  • What's the price of Phoenix Biotech Acquisition Corp. stock today?

    One share of Phoenix Biotech Acquisition Corp. stock can currently be purchased for approximately $6.32.

  • When is Phoenix Biotech Acquisition Corp.'s next earnings date?

    Unfortunately, Phoenix Biotech Acquisition Corp.'s (PBAXU) next earnings date is currently unknown.

  • Does Phoenix Biotech Acquisition Corp. pay dividends?

    No, Phoenix Biotech Acquisition Corp. does not pay dividends.

  • How much money does Phoenix Biotech Acquisition Corp. make?

    Phoenix Biotech Acquisition Corp. has a market capitalization of 36.54M.

  • What is Phoenix Biotech Acquisition Corp.'s stock symbol?

    Phoenix Biotech Acquisition Corp. is traded on the NASDAQ under the ticker symbol "PBAXU".

  • What is Phoenix Biotech Acquisition Corp.'s primary industry?

    Company operates in the Financial Services sector and Shell Companies industry.

  • How do i buy shares of Phoenix Biotech Acquisition Corp.?

    Shares of Phoenix Biotech Acquisition Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Phoenix Biotech Acquisition Corp. went public?

    Phoenix Biotech Acquisition Corp. is publicly traded company for more then 3 years since IPO on 6 Oct 2021.

  • Where are Phoenix Biotech Acquisition Corp.'s headquarters?

    Phoenix Biotech Acquisition Corp. is headquartered at 2201 Broadway, Oakland, CA.

  • How can i contact Phoenix Biotech Acquisition Corp.?

    Phoenix Biotech Acquisition Corp.'s mailing address is 2201 Broadway, Oakland, CA and company can be reached via phone at 215 731 9450.

Phoenix Biotech Acquisition Corp. company profile:

Phoenix Biotech Acquisition Corp.

Exchange:

NASDAQ

Full time employees:

0

Industry:

Shell Companies

Sector:

Financial Services

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.

215 731 9450
2201 Broadway
Oakland, CA 94612

CIK: 0001870404
ISIN: US71902K2042
CUSIP: 71902K204